Wockhardt has more than doubled investor wealth in the past year but has been an underperformer so far in 2021, up 2 percent compared with an over 12 percent rally in the Nifty 50 and the Nifty Pharma index.
The stock hit a 52-week high of Rs 804.50 on…
Small Midcap Mantra: This pharma stock is poised for a 25-40% rebound after a sharp fall
Small Midcap Mantra: This pharma stock is poised for a 25-40% rebound after a sharp fall
Share this article
More News
Bitcoin falls below $67,000 as crypto market slides
February 13, 2026
Navigating A Challenging Landscape With A 0.9% Potential Upside
February 13, 2026
Exploring A 19.44% Upside Potential
February 13, 2026
Navigating The Specialty Chemicals Landscape With A High Dividend Yield
February 13, 2026
Meme Coins Are Dragging Down the Crypto Market, Ross Gerber Says
February 13, 2026